Advertisement

Topics

"Grants Breakthrough Therapy Designation Genentech HEMLIBRA emicizumab kxwh" Drugs and Medication Database

04:22 EST 19th February 2019 | BioPortfolio

Here are the most relevant "Grants Breakthrough Therapy Designation Genentech HEMLIBRA emicizumab kxwh" Drugs and Medications that we have found in our database.

More Information about "Grants Breakthrough Therapy Designation Genentech HEMLIBRA emicizumab kxwh" on BioPortfolio

We have published hundreds of Grants Breakthrough Therapy Designation Genentech HEMLIBRA emicizumab kxwh news stories on BioPortfolio along with dozens of Grants Breakthrough Therapy Designation Genentech HEMLIBRA emicizumab kxwh Clinical Trials and PubMed Articles about Grants Breakthrough Therapy Designation Genentech HEMLIBRA emicizumab kxwh for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Grants Breakthrough Therapy Designation Genentech HEMLIBRA emicizumab kxwh Companies in our database. You can also find out about relevant Grants Breakthrough Therapy Designation Genentech HEMLIBRA emicizumab kxwh Drugs and Medications on this site too.

Showing "Grants Breakthrough Therapy Designation Genentech HEMLIBRA emicizumab kxwh" Drugs and Medications, all 16

Relevant

Hemlibra [genentech, inc.]

These highlights do not include all the information needed to use HEMLIBRA safely and effectively. See full prescribing information for HEMLIBRA. HEMLIBRA (emicizumab-kxwh) injection, for subcutaneous use Initial U.S. Approval: 2017

Sterile water [genentech, inc.]

Sterile Water for Injection, USP

Probably Relevant

Feiba [baxalta incorporated]

These highlights do not include all the information needed to use FEIBA safely and effectively. See full prescribing information for FEIBA. FEIBA, anti-inhibitor coagulant complex for intravenous use, lyophilized powder for solutionInitial U.S. Approval:

Possibly Relevant

Xolair [genentech, inc.]

These highlights do not include all the information needed to use XOLAIR safely and effectively. See full prescribing information for XOLAIR. XOLAIR (omalizumab) injection, for subcutaneous useXOLAIR (omalizumab) for injection, for subcutaneous useInitial

Cellcept [genentech, inc.]

These highlights do not include all the information needed to use CELLCEPT safely and effectively. See full prescribing information for CELLCEPT CELLCEPT (mycophenolate mofetil) capsules, for oral useCELLCEPT (mycophenolate mofetil) tablets, for oral useC

Doxycycline [directrx]

DOXYCYCLINE

Fuzeon [genentech, inc.]

These highlights do not include all the information needed to use FUZEON safely and effectively. See full prescribing information for FUZEON. FUZEON (enfuvirtide) for Injection Initial U.S. Approval: 2003

Pulmozyme [genentech, inc.]

These highlights do not include all the information needed to use PULMOZYME safely and effectively. See full prescribing information for PULMOZYME. PULMOZYME (dornase alfa) inhalation solution, for inhalation use Initial U.S. Approval: 1993

Esbriet [genentech, inc.]

These highlights do not include all the information needed to use ESBRIET safely and effectively. See full prescribing information for ESBRIET. ESBRIET (pirfenidone) capsules and film-coated tablets, for oral useInitial U.S. Approval: 2014

Omega-3-acid ethyl esters [par pharmaceutical, inc.]

These highlights do not include all the information needed to use Omega-3-acid ethyl esters safely and effectively. See full prescribing information for Omega-3-acid ethyl esters capsules.Omega-3-Acid Ethyl Esters Capsules, USP for oral useInitial U.S. Ap

Omega-3-acid ethyl esters [a-s medication solutions]

These highlights do not include all the information needed to use Omega-3-acid ethyl esters safely and effectively. See full prescribing information for Omega-3-acid ethyl esters capsules.Omega-3-Acid Ethyl Esters Capsules, USP for oral useInitial U.S. Ap

Omega-3-acid ethyl esters [bryant ranch prepack]

These highlights do not include all the information needed to use Omega-3-acid ethyl esters safely and effectively. See full prescribing information for Omega-3-acid ethyl esters capsules.Omega-3-Acid Ethyl Esters Capsules, USP for oral useInitial U.S. Ap

Omega-3-acid ethyl esters [golden state medical supply, inc.]

Omega-3-Acid Ethyl Esters Capsules These highlights do not include all the information needed to use Omega-3-acid ethyl esters safely and effectively. See full prescribing information for Omega-3-acid ethyl esters capsules. Omega-3-Acid Ethyl Esters Capsu

Naprosyn [genentech, inc.]

EC-NAPROSYN (naproxen delayed-release tablets) NAPROSYN (naproxen tablets) ANAPROX/ANAPROX DS (naproxen sodium tablets) NAPROSYN (naproxen suspension)

Erivedge [genentech, inc.]

These highlights do not include all the information needed to use ERIVEDGE safely and effectively. See full prescribing information for ERIVEDGE. ERIVEDGE (vismodegib) capsule for oral use Initial U.S. Approval: 2012

Lovaza [physicians total care, inc.]

These highlights do not include all the information needed to use LOVAZA safely and effectively. See full prescribing information for LOVAZA. LOVAZA® (omega-3-acid ethyl esters) Capsules Initial U.S. Approval: 2004



Advertisement
Quick Search
Advertisement
Advertisement